Free Trial
ASX:SMR

Stanmore Resources (SMR) Stock Price, News & Analysis

Stanmore Resources logo

About Stanmore Resources Stock (ASX:SMR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.20 million shs
Average Volume
N/A
Market Capitalization
A$1.48 billion
P/E Ratio
5.40
Dividend Yield
7.45%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stanmore Resources and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SMR Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel
See More Headlines

SMR Stock Analysis - Frequently Asked Questions

Stanmore Resources Limited (ASX:SMR) issued its quarterly earnings data on Tuesday, February, 12th. The company reported $0.08 EPS for the quarter. Stanmore Resources had a trailing twelve-month return on equity of 15.63% and a net margin of 10.57%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stanmore Resources investors own include Aldeyra Therapeutics (ALDX), Biodexa Pharmaceuticals (BDRX), Candel Therapeutics (CADL), Cleanspark (CLSK), CXApp (CXAI), DiaMedica Therapeutics (DMAC) and Dyne Therapeutics (DYN).

Company Calendar

Last Earnings
2/12/2019
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Coking Coal
Sub-Industry
Fabricated Products
Current Symbol
ASX:SMR
CIK
N/A
Fax
N/A
Employees
440
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.44
Trailing P/E Ratio
5.40
Forward P/E Ratio
N/A
P/E Growth
0.03
Net Income
A$268.40 million
Net Margins
10.57%
Pretax Margin
N/A
Return on Equity
15.63%
Return on Assets
7.75%

Debt

Debt-to-Equity Ratio
44.24
Current Ratio
1.01
Quick Ratio
1.27

Sales & Book Value

Annual Sales
A$2.54 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.69
Book Value
A$1.95 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
901,390,000
Free Float
N/A
Market Cap
A$1.48 billion
Optionable
Not Optionable
Beta
0.21
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ASX:SMR) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners